Evaluation Scores (ECRI)
Task Force guidelines get high marks internationally
ECRI Evaluation Scores
ECRI Guidelines Trust scores guidelines based on their adherence to the National Academy of Medicine Standards for Trustworthy Guidelines. ECRI scores the guidelines using the NEATS Instrument on a scale of 1 to 5, across 12 standards. The standards are described here.
The table below provides each Task Force guidelines’ scores. Each column represents a standard. A score of “5” = highest adherence to the standard; a score of “1” = lowest adherence to the standard.
Legend
🟢 Score = 5 or “yes”
🔵 Score = 4
🟡 Score = 3
🟠 Score = 2
🔴 Score = 1 or “no”
| Guideline | Composition of Guideline Development Group (GDG) | Systematic Review of Evidence | Foundations for Recommendations | Funding Source | Disclosure and Management of Financial Conflicts of Interest | External Review | Updating | ||||||||
| Multidisciplinary GDG Members | Methodologist Involvement | Incorporation of Patient and Public Perspective | Literature Search | Study Selection | Evidence Synthesis | Strength of Evidence Grade | Description of Benefits and Harms of Recommendations | Summary of Evidence Supporting Recommendations | Strength of Recommendations Rating | Clear Articulation of Recommendations | |||||
| Abdominal Aortic Aneurysm (2017) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Asymptomatic Bacteriuria in Pregnancy (2018) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Asymptomatic Thyroid Dysfunction (2019) | Yes 🟢 | Yes 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Breast Cancer (2018) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 |
| Chlamydia & Gonorrhea (2021) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Cognitive Impairment (2016) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 3/5 🟡 | 5/5 🟢 |
| Colorectal Cancer (2016) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Depression during Pregnancy and the Postpartum Period (2022) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Developmental Delay (2016) | Yes 🟢 | Yes 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Esophageal Adenocarcinoma (2020) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Fragility Fractures (2023) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Hepatitis C (2017) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Impaired Vision (2018) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Lung Cancer (2016) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |
| Tobacco Smoking in Children and Adolescents (2017) | Yes 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | 4/5 🔵 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 | Yes 🟢 | 5/5 🟢 | 5/5 🟢 | 5/5 🟢 |